Robert G. Micheletti, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Headshot of Robert G. Micheletti, MD
Penn Medicine Provider

About me

  • Chief of Hospital Dermatology
  • Chief of Dermatology, Pennsylvania Hospital
  • Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center
  • Director, Dermatology Medical Student Elective
  • Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Associate Professor of Dermatology in Medicine (Rheumatology)

My education and training

  • Medical School: Duke University Medical Center
  • Residency: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital
Dr. Micheletti is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Lewis W, Micheletti RG Dermal Atrophy and Lipoatrophy , Decision-Making in Dermatology: 2026


Lewis W, Micheletti RG Epidermal Atrophy , Decision-Making in Dermatology: 2026


Micheletti RG, Song WB, Chu B, Allen-Taylor L, Gelfand JM, Grayson PC, Ponte C, Robson JC, Suppiah R, Luqmani RA, Watts RA, Merkel PA; DCVAS Investigators Cutaneous Manifestations of Vasculitis: A Cross-Sectional Analysis from an International Cohort , Int J Dermatol: 2026


Alladeen A, Cho SK, Micheletti RG. Hospital Dermatology: Review of Research in 2024-2025. , Cutis , 117((4)): 2026,109-113


Micheletti RG Featured in: "Vasculitis Evaluation and Management" , Dialogues in Dermatology Podcast: 2026


Micheletti RG Featured in: "Bridging Science and Support: Initiating biologics in patients with hidradenitis suppurativa" , SkinSync Podcast: 2026


Mahajan A, Song W, Walls AC, Mostaghimi A, Micheletti R, Piette EW Point-of-Care Risk Factors for Systemic Disease in Patients with Small Vessel Vasculitis of the Skin , JAMA Dermatol, 162(1): 2026,94-7


Martin-Pozo MD, Williams EA, Bonnet KR, Kaffenberger BH, Schlundt DG, Phillips EJ; SJS Survivor Study Recovering from Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis , JAMA Dermatol, 162(1): 2026,24-30


Drucker AM, Williams E, Kaffenberger B, Dodiuk-Gad RP, Chren MM, Phillips S, Martin-Pozo M, Goh MS, Ergen E, Micheletti R, Rosenbach M, Yu A, O'Connor A, Mahan K, Phillips EJ Long-term morbidity and quality of life among survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum , Br J Dermatol, 194(1): 2026,161-63


Micheletti RG, Requena L, Callen JP Cutaneous Vasculitis and Panniculitis , Rheumatology, 9th Edition: 2026